This company has been marked as potentially delisted and may not be actively trading. NASDAQ:LNDC Landec (LNDC) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Landec Stock (NASDAQ:LNDC) 30 days 90 days 365 days Advanced Chart Get Landec alerts:Sign Up Key Stats Today's Range N/A50-Day Range$8.05▼$9.9552-Week Range N/AVolume1,739 shsAverage Volume84,032 shsMarket Capitalization$259.26 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Landec Corporation, together with its subsidiaries, designs, develops, manufactures, and sells differentiated health and wellness products for food and biomaterials markets in the United States and internationally. It operates through Lifecore, Curation Foods, and Other segments. The Lifecore segment engages in the manufacture of pharmaceutical-grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a range of medical conditions and procedures. It also provides services, including technology development, material component changes, analytical method development, formulation development, pilot studies, stability studies, process validation, and production of materials for clinical studies to its partners for HA-based and non-HA based aseptically formulated and filled products. This segment sells its non-HA products for medical use primarily in the ophthalmic, orthopedic, and other markets. The Curation Foods segment engages in processing, marketing, and selling of olive oils and wine vinegars under the O brand; and guacamole and avocado food products under the Yucatan and Cabo Fresh brands, as well as various private labels. Landec Corporation was incorporated in 1986 and is headquartered in Santa Maria, California. Read More Receive LNDC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Landec and its competitors with MarketBeat's FREE daily newsletter. Email Address LNDC Stock News HeadlinesROSEN, NATIONAL TRIAL LAWYERS, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation - LFCR, LNDCMay 13, 2024 | prnewswire.comROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation - LFCR, LNDCMay 5, 2024 | prnewswire.comMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI. | Brownstone Research (Ad)ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation - LFCR, LNDCApril 29, 2024 | prnewswire.comROSEN, SKILLED INVESTOR COUNSEL, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation - LFCR, LNDCApril 19, 2024 | prnewswire.comLFCR INVESTOR NEWS: ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Lifecore Biomedical Inc. f/k/a Landec Corporation Investors to Inquire About Securities Class Action Investigation - LFCR, LNDCApril 12, 2024 | prnewswire.comPunjab National Bank 532461January 17, 2024 | morningstar.comMLandec is about to announce its earnings — here's what to expectSeptember 1, 2023 | markets.businessinsider.comSee More Headlines LNDC Stock Analysis - Frequently Asked Questions How were Landec's earnings last quarter? Landec Co. (NASDAQ:LNDC) released its earnings results on Tuesday, September, 28th. The basic materials company reported ($0.23) EPS for the quarter, missing the consensus estimate of ($0.11) by $0.12. The basic materials company earned $128.79 million during the quarter, compared to analysts' expectations of $128.25 million. Landec had a negative trailing twelve-month return on equity of 16.79% and a negative net margin of 36.49%. Does Landec have any subsidiaries? Landec subsidiaries include Yucatan Foods, O Olive Oil, GreenLine Holding, Lifecore, Heartland Hybrids, Apio, Dock Resins, and Curation Foods Inc.. What other stocks do shareholders of Landec own? Based on aggregate information from My MarketBeat watchlists, some other companies that Landec investors own include Honda Motor (HMC), Comerica (CMA), Walt Disney (DIS), General Mills (GIS), Exxon Mobil (XOM), Cenovus Energy (CVE) and Intel (INTC). Company Calendar Last Earnings9/28/2021Today8/07/2025Fiscal Year End5/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical preparations Sub-IndustrySpecialty Chemicals Current SymbolNASDAQ:LNDC CIK1005286 Webwww.landec.com Phone(650) 306-1650Fax650-368-9818Employees905Year Founded1986Profitability EPS (Trailing Twelve Months)($3.38) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$97.43 million Net Margins-36.49% Pretax Margin-20.04% Return on Equity-16.79% Return on Assets-6.38% Debt Debt-to-Equity Ratio0.99 Current Ratio1.40 Quick Ratio0.63 Sales & Book Value Annual Sales$185.79 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow2.55 Book Value$3.66 per share Price / BookN/AMiscellaneous Outstanding Shares29,596,000Free Float25,272,000Market Cap$259.26 million OptionableOptionable Beta1.10 Social Links Options Trading Made Easy - Download NowLearn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.Get This Free Report This page (NASDAQ:LNDC) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredAmazon’s big Bitcoin embarrassmentBitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...Brownstone Research | SponsoredCritical AI announcement set to ignite AI 2.0 A new 100% tariff on imported chips just rattled the tech sector—sending some stocks soaring and others tumbli...Timothy Sykes | SponsoredTrump’s new nightmareAccording to Porter Stansberry and Jeff Brown, a government-led financial mobilization is already reshaping Am...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Landec Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Landec With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.